𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Errors in measurement and reporting of serum markers in patients with germ cell tumors

✍ Scribed by Fredric M. Kardon; John G. Krikorian; JoséA. Lopez; Ralph devere White

Book ID
119044627
Publisher
Elsevier Science
Year
1982
Tongue
English
Weight
291 KB
Volume
20
Category
Article
ISSN
0090-4295

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tra-1-60: A new serum marker in patients
Tra-1-60: A new serum marker in patients with germ-cell tumors
✍ J. Marrink; P. W. Andrews; P. J. Van Brummen; H. J. De Jong; D. T. H. Sleijfer; 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 French ⚖ 506 KB

TRA-1-60 is a monoclonal antibody (MAb) that recognizes a mucin-like antigenic determinant expressed on the surface of embryonal carcinoma (EC) progenitor cells. In order to determine whether this antigen is released into the serum of patients with a non-seminomatous germ-cell tumor (NSGCT), we deve

Serum tumor markers and patient allocati
Serum tumor markers and patient allocation to good-risk and poor-risk clinical trials in patients with germ cell tumors
✍ George J. Bosl; Nancy L. Geller; Dean Bajorin 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 552 KB

The allocation of patients with advanced germ cell tumors (GCT) to different treatment programs based on clinical characteristics is standard in the design of clinical trials today. Studies have shown that substantial differences exist between entry criteria and that these differences could influenc

Tumor markers at the time of recurrence
Tumor markers at the time of recurrence in patients with germ cell tumors
✍ José M. Trigo; José M. Tabernero; Luis Paz-Ares; José L. García-Llano; José Mora 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

BACKGROUND. ␣-fetoprotein (AFP), human chorionic gonadotropin (HCG), and lactate dehydrogenase (LDH) closely follow the course of germ cell tumors (GCTs) and are widely used for diagnosis, prognosis, and follow-up purposes. The objective of this study was to assess the concordance of tumor markers a

Clinical use of serum TRA-1-60 as tumor
Clinical use of serum TRA-1-60 as tumor marker in patients with germ cell cancer
✍ Henrik Lajer; Gedske Daugaard; Anna-Maria Andersson; Niels Erik Skakkebæk 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 69 KB 👁 1 views

## Abstract TRA‐1‐60 antigen has been related to the presence of embryonal germ cell carcinoma (EC) and carcinoma __in situ__. Our study further investigated the clinical efficacy of TRA‐1‐60 as a serum tumor marker for germ cell cancer in the testis. Three groups of patients with germ cell tumors